Filing Details

Accession Number:
0001415889-24-023032
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-06 17:37:07
Reporting Period:
2024-09-04
Accepted Time:
2024-09-06 17:37:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1855644 Zura Bio Ltd ZURA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870329 Someit Sidhu
4001 Kennett Pike, Suite 302
Wilmington DE 19807
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Disposition 2024-09-04 51,728 $3.87 2,085,418 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Ordinary Shares 1,186,901 Indirect By Pegasus LLC
Class A Ordinary Shares 351,000 Indirect By JATT Ventures, L.P.
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.86 to $3.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The shares are directly held by Pegasus LLC. The Reporting Person is the sole member of Pegasus LLC and the Reporting Person may be deemed to have voting and dispositive power over the shares held by Pegasus LLC. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein.
  3. The shares are directly held by JATT Ventures, L.P. ("JATT"). The Reporting Person is the sole director of the sole general partner of JATT and may be deemed to have voting and dispositive power over the shares held by JATT. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein.